论文部分内容阅读
目的研究华法林在预防心房颤动(以下简称房颤)栓塞中的临床效果。方法整理新密市第一人民医院108例房颤患者的临床资料,随机分为治疗组和对照组,每组54例,分别给予华法林及常规治疗护理,对患者的房颤并发栓塞的情况进行统计研究。结果治疗组患者的栓塞情况明显少于对照组患者,在治疗预防的过程中效果较为明显,两组相比差异有统计学意义(P<0.05)。结论预防房颤栓塞时,给予患者华法林进行常规护理治疗使INR波动于1.5～2.5,可减少患者的栓塞等并发症发生率,提高患者的健康度和治疗有效率,值得在临床上进行推广使用。
Objective To study the clinical effect of warfarin in preventing embolism of atrial fibrillation (AF). Methods The clinical data of 108 patients with atrial fibrillation in Xinmi First People’s Hospital were randomly divided into treatment group and control group, with 54 cases in each group. The patients were given warfarin and routine nursing care respectively. Patients with atrial fibrillation complicated by embolism Statistical analysis of the situation. Results The embolization of the treatment group was significantly less than that of the control group, and the effect was obvious in the course of treatment and prevention. There was significant difference between the two groups (P <0.05). Conclusion Prevention of atrial fibrillation embolism, warfarin given to patients with routine care treatment INR fluctuations in 1.5 to 2.5, can reduce the incidence of complications such as embolization in patients with increased patient health and treatment efficiency, it is worth in the clinical Promote use.